GGrantIndex
← Leaderboards

Rhoda Au

Boston University Medical Campus

$25,469,110
Attributed
$38,383,764
Total exposure
20
Grants
16
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $11.5M · FY201025
$20M$15M$10M$5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$74,051,174 · 22

By mechanism

U19$42,163,618 · 4
R01$15,335,887 · 7
RF1$7,560,948 · 3
U54$6,393,548 · 2
R56$1,151,522 · 2
R21$625,071 · 2

Most similar at Boston University Medical Campus

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposCommunitiesS DiseaseCohortDementiaFramingham Heart StudyCognitiveStructureBrainImpaired CognitionParticipantGenerationsBaseGeneticDiagnosisNeuropsychological TestsS Disease RiskRisk FactorsDigitalMagnetic Resonance ImagingMri ScansBiological MarkersResponseCognition

Grant awards (59)

NBER Coordinating Center on the Economics of AD/ADRD Prevention, Treatment, and Care.$2,906,646
U54 · FY2025 · AG
Cognitive heterogeneity in those with high Alzheimer's Disease Risk$817,404
R01 · FY2025 · AG · contact PI
Digital Cognitive Assessment of Preclinical Alzheimer's Disease and Related Dementias$792,380
R01 · FY2025 · AG · contact PI
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study$569,405
R01 · FY2025 · AG · contact PI
Stakeholder Engagement Core$278,863
U54 · FY2025 · AG · contact PI
Leading equitable research in Alzheimer's disease in Africa (LEAD Africa)$201,339
UG3 · FY2025 · AG · contact PI
Leading equitable research in Alzheimer's disease in Africa (LEAD Africa)$90,715
UG3 · FY2025 · AG · contact PI
Leading equitable research in Alzheimer's disease in Africa (LEAD Africa)$84,626
UG3 · FY2025 · AG · contact PI
Leading equitable research in Alzheimer's disease in Africa (LEAD Africa)$83,903
UG3 · FY2025 · AG · contact PI
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia$5,130,473
U19 · FY2024 · AG
NBER Coordinating Center on the Economics of AD/ADRD Prevention, Treatment, and Care.$2,929,176
U54 · FY2024 · AG
Clinical Core$2,277,855
U19 · FY2024 · AG · contact PI
Digital Cognitive Assessment of Preclinical Alzheimer's Disease and Related Dementias$835,868
R01 · FY2024 · AG · contact PI
Stakeholder Engagement Core$278,863
U54 · FY2024 · AG · contact PI
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia$6,526,335
U19 · FY2023 · AG
Clinical Core$2,542,714
U19 · FY2023 · AG · contact PI
Expanding the Pipeline to Graduate Research in Alzheimer's Disease and Related Dementias (EPGRAD) Program$359,997
R25 · FY2023 · AG
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study: Black & AA Recruitment Supplement$251,771
RF1 · FY2023 · AG · contact PI
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia$5,451,688
U19 · FY2022 · AG
Clinical Core$2,557,564
U19 · FY2022 · AG · contact PI
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia: Supplement; Framingham Heart Study Brain Aging Program (FHS-BAP)$1,433,058
U19 · FY2022 · AG
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study$346,463
RF1 · FY2022 · AG · contact PI
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia$5,319,931
U19 · FY2021 · AG
Clinical Core$2,538,804
U19 · FY2021 · AG · contact PI
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study$1,836,408
RF1 · FY2021 · AG · contact PI
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia$426,435
U19 · FY2021 · AG
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia$298,773
U19 · FY2021 · AG
Cognitive Heterogeneity in those with high Alzheimer's Disease Risk$235,089
RF1 · FY2021 · AG · contact PI
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia$5,244,895
U19 · FY2020 · AG
Clinical Core$2,415,093
U19 · FY2020 · AG · contact PI
Cognitive Heterogeneity in those with high Alzheimer's Disease Risk$1,532,717
RF1 · FY2020 · AG · contact PI
MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults$1,004,154
R01 · FY2019 · AG · contact PI
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$335,585
R01 · FY2019 · AG
MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults$1,026,714
R01 · FY2018 · AG · contact PI
Cognitive heterogeneity in those with high Alzheimer's Disease Risk$517,295
R56 · FY2018 · AG · contact PI
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$335,585
R01 · FY2018 · AG
MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults$321,397
R01 · FY2018 · AG · contact PI
Epigenetic changes in synaptic and inflammatory genes involved in the age-dependent development of Alzheimer's disease pathologies and cognitive decline$311,406
RF1 · FY2018 · AG
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$288,435
R01 · FY2018 · AG
MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults$1,038,541
R01 · FY2017 · AG · contact PI
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$335,585
R01 · FY2017 · AG
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$164,500
R01 · FY2017 · AG
Impact of Traumatic Brain Injury on Brain Aging and Dementia$160,776
R21 · FY2017 · HD · contact PI
Epigenetic changes in synaptic and inflammatory genes involved in the age-dependent development of Alzheimer's disease pathologies andcognitive decline$3,047,094
RF1 · FY2016 · AG
MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults$1,063,951
R01 · FY2016 · AG · contact PI
MRI, Genetics & Cognitive Precursors of AD and Dementia$634,478
R01 · FY2016 · AG · contact PI
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$335,585
R01 · FY2016 · AG
Impact of Traumatic Brain Injury on Brain Aging and Dementia$194,854
R21 · FY2016 · HD · contact PI
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$164,357
R01 · FY2016 · AG
Epidemiology of Dementia in the Framingham Study$1,308,091
R01 · FY2015 · AG
MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults$1,048,692
R01 · FY2015 · AG · contact PI
MRI, Genetics & Cognitive Precursors of AD and Dementia$620,330
R01 · FY2015 · AG · contact PI
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study$335,585
R01 · FY2015 · AG
MRI, Genetics & Cognitive Precursors of AD and Dementia$641,620
R01 · FY2014 · AG · contact PI
Precursors and Prognosis of Traumatic Brain Injury in Young to Middle Aged Adults$634,227
R56 · FY2014 · NS · contact PI
MRI, Genetics & Cognitive Precursors of AD and Dementia$609,801
R01 · FY2013 · AG · contact PI
MRI, Genetics & Cognitive Precursors of AD and Dementia$707,844
R01 · FY2012 · AG
Epidemiology of Mild Cognitive Impairment and Dementia in China$126,850
R21 · FY2011 · TW · contact PI
Epidemiology of Mild Cognitive Impairment and Dementia in China$142,591
R21 · FY2010 · TW · contact PI